The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.
Learn more about upcoming clinical trials for those at risk for NASH (Nonalcoholic Steatohepatitis)
Are you planning, or have you been told that you need a total knee replacement? You may qualify for an upcoming clinical trial.
ECT is looking for participants for upcoming clinical trials. Learn more about getting involved today.
